Asia Pacific Placenta Market Outlook

asia pacific is home to a vast number of countries, each with their own unique culture and demographics. the demand for placenta derived products, such as dietary supplements exceeding natural dietary deficiencies, continues to grow in the region. this demand can be attributed to an increasing middle-class population, as well as an aging population with a preference for natural health remedies. the asia pacific market is expected to see a surge in the demand for placental products over the forecast period of 2018-2032. the growth is expected to come from the region’s population of over 4.5 billion. this will be fuelled by a number of factors including, increasing disposable incomes, lifestyle changes and changing consumer preferences. changes in consumer behavior will be driven by an increasing awareness of natural remedies. health professionals, and alternative healthcare professionals are pushing the use of placenta derived products for treatment and prevention of diseases. these products are also being used by sport organizations and athletes for performance enhancement. further, changing dietary habits, a growing vegetarian population and increasing use of traditional asian medicines are also expected to drive market demand. government policies regarding the sale and production of placenta derived products is expected to be a major market determining factor. china, india and japan have stringent regulations, as well as strict licensing processes, for the sale of placental products. korea has outlawed the production of such products while thailand and vietnam are strict when it comes to the import and export. these regulations may have a direct impact on the supply side of the market, as well as its overall growth. the availability of the product in the market is also an issue. as we all know, placenta is a bi-product, meaning it is a by-product of childbirth or of human conception, and is not always available on the open market. this means that the demand for placenta derived products is mainly met through medical and healthcare channels, as hospitals and physicians tend to still be the main source of the placenta. therefore, the asia pacific market for placenta derived products is expected to grow over the forecast period of 2018-2032, driven by a combination of factors. these include changes in consumer behavior, government regulations, and limited availability of the placenta.